Clinical evalution of Oma Ilagam (Internal) and Sangamver Thylam (External)for the managaement of Kalanjapadai(Psoriasis) in children
- Conditions
- Psoriasis, unspecified,
- Registration Number
- CTRI/2021/08/035820
- Lead Sponsor
- OPD IPD Ayothidoss Pandithar hospital National institite of siddha
- Brief Summary
Psoriasis is a common chronic skin disease
In the pediatric OPD of NIS nearly 10000 patient had recorded with the symptom of psoriasis from 2018 to 2019
Children are not aware of this condition because it doesnot cause any painful symptom to them
The selected experimental drugs namely oma ilagam and sangamver thylam are indicated for the disease kuttam according to siddha literature including kalanjapadai
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
Patient with two or more of the following symptoms Scaling Erythema With or without itching Candle crease sign positive Dryness of skin Cracks followed by itching Auspitz sign positive Thickness.
Psoriatic arthritis Eczema Psoriasis with evidence od any other skin disease Fungal infection Any other systemic disorder Lesion with secondary infection Epilepsy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efiicacy of the trial drug is measured by PASI score and improvement in the clinical condition is assured by reducing the degrees of involvement of the body region from 5 to 1 45 days
- Secondary Outcome Measures
Name Time Method Reduction in the remission of the disease and improvement in the qualitu of life in children Quality of life will be measured with standard published questionarie
Trial Locations
- Locations (1)
OPD IPD Ayothidoss pandithar hospital National institite of siddha
🇮🇳Kancheepuram, TAMIL NADU, India
OPD IPD Ayothidoss pandithar hospital National institite of siddha🇮🇳Kancheepuram, TAMIL NADU, IndiaDr A MaruthabaraniPrincipal investigator7708626626drmaruthabarani@gmail.com